Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2023 | 2.341 |
| June 28, 2023 | 2.321 |
| June 27, 2023 | 2.325 |
| June 26, 2023 | 2.338 |
| June 23, 2023 | 2.402 |
| June 22, 2023 | 2.418 |
| June 21, 2023 | 2.380 |
| June 20, 2023 | 2.367 |
| June 16, 2023 | 2.413 |
| June 15, 2023 | 2.424 |
| June 14, 2023 | 2.428 |
| June 13, 2023 | 2.424 |
| June 12, 2023 | 2.510 |
| June 09, 2023 | 2.510 |
| June 08, 2023 | 2.549 |
| June 07, 2023 | 2.530 |
| June 06, 2023 | 2.477 |
| June 05, 2023 | 2.424 |
| June 02, 2023 | 2.424 |
| June 01, 2023 | 2.391 |
| May 31, 2023 | 2.391 |
| May 30, 2023 | 2.362 |
| May 26, 2023 | 2.376 |
| May 25, 2023 | 2.358 |
| May 24, 2023 | 2.376 |
| Date | Value |
|---|---|
| May 23, 2023 | 2.411 |
| May 22, 2023 | 2.384 |
| May 19, 2023 | 2.301 |
| May 18, 2023 | 2.246 |
| May 17, 2023 | 2.244 |
| May 16, 2023 | 2.220 |
| May 15, 2023 | 2.314 |
| May 12, 2023 | 2.226 |
| May 11, 2023 | 2.255 |
| May 10, 2023 | 2.29 |
| May 09, 2023 | 2.255 |
| May 08, 2023 | 2.310 |
| May 05, 2023 | 2.345 |
| May 04, 2023 | 2.325 |
| May 03, 2023 | 2.310 |
| May 02, 2023 | 2.292 |
| May 01, 2023 | 2.345 |
| April 28, 2023 | 2.288 |
| April 27, 2023 | 2.29 |
| April 26, 2023 | 2.29 |
| April 25, 2023 | 2.314 |
| April 24, 2023 | 2.323 |
| April 21, 2023 | 2.362 |
| April 20, 2023 | 2.349 |
| April 19, 2023 | 2.384 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Rigel Pharmaceuticals, Inc. | 1.980 |
| Marker Therapeutics, Inc. | 2.056 |
| Verastem, Inc. | 12.40 |
| Theriva Biologics, Inc. | 0.9038 |
Price to Book Value Related Metrics
| PE Ratio | 5.380 |
| PS Ratio | 1.785 |
| Price to Free Cash Flow | 3.746 |
| Price | 4.125 |
| Earnings Yield | 18.59% |
| Market Cap | 681.61M |
| Operating PE Ratio | 2.945 |
| Normalized PE Ratio | 5.328 |